Get started
Author

Adam Waxman

Observed name: Adam J. Waxman
OpenAlex ID: A5135927020
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis
2026 · Efstathios Kastritis, Giovanni Palladini, et al. · Blood · 4
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials
2026 · Ashutosh D. Wechalekar, Angela Dispenzieri, et al. · Journal of Clinical Oncology · 2
LBA-17 Cevostamab Consolidation Following BCMA CAR T Cell Therapy: Primary Analysis of the Phase 2 “STEM” (Sequential T Cell-Engagement for Myeloma) Trial
2026 · Adam D. Cohen, Sandra Susanibar-Adaniya, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Atrial Fibrillation Risk and Cardiovascular Events After Hematopoietic Cell Transplantation
2026 · Robert Monsour, Kyunga Ko, et al. · JACC CardioOncology
Works count: 5
Citation count: 11
H-index: 2
I10-index:
Year
Topic
Type